Clinical Trials · NCT00776074
A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Takeda
- Enrollment
- 80
- Start date
- Jun 2006
- Locations
- See registry
- Primary endpoint
- Percentage of measured E2 (17β-estradiol) Serum Concentrations less than or equal to 30 pg/mL.